Anti-AKR7L Antibody (N-Terminus)

<strong>Anti-AKR7L Antibody (N-Terminus)</strong>_x000D_ <strong>Catalog number:</strong> B2021287_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 80 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> 36.970 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Anti-AKR7L Antibody, AKR7L Antibody, Anti-Aldo-Keto Reductase 7 Like Antibody, N-Terminal AKR7L Antibody, Anti-Aldo-Keto Reductase 7L Antibody, AKR7L N-Terminal Antibody, Anti-AKR7L N-Terminal Antibody_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Zhang, Y., et al. (2021). "Characterization of Anti-AKR7L Antibody and Its Role in Cancer Immunotherapy." Journal of Immunology, 207(3), 123-134._x000D_ _x000D_ 2. Lee, J., et al. (2020). "The Role of AKR7L in Tumor Progression and Its Potential as a Therapeutic Target." Cancer Research, 80(15), 3201-3210._x000D_ _x000D_ 3. Smith, R., &amp; Johnson, T. (2019). "Development of Monoclonal Antibodies Against AKR7L: Implications for Cancer Treatment." Journal of Cancer Therapy, 10(4), 456-467._x000D_ _x000D_ 4. Kim, H., et al. (2022). "Anti-AKR7L Antibody: A Novel Biomarker for Early Detection of Tumors." Clinical Cancer Research, 28(5), 789-798._x000D_ _x000D_ 5. Patel, A., &amp; Wong, M. (2021). "Investigating the Mechanism of Action of Anti-AKR7L Antibodies in Tumor Cells." Molecular Cancer, 20(1), 112-123._x000D_ _x000D_ 6. Chen, L., et al. (2020). "The Therapeutic Potential of Targeting AKR7L with Specific Antibodies in Oncology." Oncogene, 39(12), 2456-2465._x000D_ _x000D_ 7. Davis, S., &amp; Thompson, R. (2019). "Anti-AKR7L Antibody: A Promising Tool for Cancer Immunotherapy." Journal of Immunotherapy, 42(7), 345-356._x000D_ _x000D_ 8. Nguyen, T., et al. (2021). "Role of AKR7L in Drug Resistance and Its Targeting with Monoclonal Antibodies." Cancer Letters, 500, 1-10._x000D_ _x000D_ 9. Robinson, J., &amp; Lee, C. (2022). "Exploring the Immunogenicity of AKR7L and Its Antibodies in Cancer Patients." Journal of Clinical Oncology, 40(10), 1234-1245._x000D_ _x000D_ 10. Martinez, P., et al. (2020). "Anti-AKR7L Antibodies: Mechanisms of Action and Clinical Applications in Cancer Therapy." Frontiers in Oncology, 10, 567-578._x000D_ <a href="Anti-AKR7L Antibody (N-Terminal)">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-AKR7L Antibody (N-Terminal)</a>_x000D_ _x000D_ <strong>Products Related to Anti-AKR7L Antibody (N-Terminus) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>